Faculty profile for Dr. Christopher D. Blosser. Dr. Blosser is a transplant nephrologist and medical director of the Cancer ...

Fred Hutch board members Ric Anderson and Eduardo Peñalver take on new leadership roles, Jim Lico joins Board of Directors ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only ...

Investigators in the Clinical Research Division’s Program in Immunology are also members of the cross-divisional Immunotherapy Integrated Research Center (IIRC). Together, they are focused on learning ...

Clinical Laboratory Improvement Amendments, or CLIA, are a high bar as set by the US Government under Clinical Laboratory Improvement Amendment 42 CFR 493.1253 to obtain and maintain quality ...

The Co-Operative Center for Excellence in Hematology Cell Procurement & Processing Lab currently has an active protocol which allows one to participate as a Donor of Peripheral Blood Mononuclear Cells ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

IDS Key Areas of Research. Our physicians and scientists apply their extensive experience in immunocompetent and immunocompromised populations to study the epidemiology of infectious diseases, ...